uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
10.65
+1.61 (17.81%)
Mar 5, 2026, 4:00 PM EST - Market closed
uniQure Employees
uniQure had 209 employees as of December 31, 2024. The number of employees decreased by 271 or -56.46% compared to the previous year.
Employees
209
Change (1Y)
-271
Growth (1Y)
-56.46%
Revenue / Employee
$77,024
Profits / Employee
-$952,014
Market Cap
663.41M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 209 | -271 | -56.46% |
| Dec 31, 2023 | 480 | -21 | -4.19% |
| Dec 31, 2022 | 501 | 38 | 8.21% |
| Dec 31, 2021 | 463 | 131 | 39.46% |
| Dec 31, 2020 | 332 | 84 | 33.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MeiraGTx Holdings | 409 |
| Allogene Therapeutics | 229 |
| CorMedix | 65 |
| Larimar Therapeutics | 65 |
| Design Therapeutics | 55 |
| Fulcrum Therapeutics | 55 |
| Contineum Therapeutics | 41 |
QURE News
- 9 hours ago - Federal health officials attacked an Amsterdam-based biotech company seeking approval of a Huntington's disease treatment and accused it of lying - WSJ
- 12 hours ago - FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease - CNBC
- 14 hours ago - Sr. FDA official calls Uniqure's Huntington's disease treatment a failure - Reuters
- 15 hours ago - FDA Defends Call For Placebo Study In uniQure Huntington's Gene Therapy Trial - Benzinga
- 1 day ago - FDA official says UniQure fell short on Huntington's trial, defends new study request - Reuters
- 2 days ago - These Analysts Cut Their Forecasts On uniQure Following Q4 Results - Benzinga
- 2 days ago - uniQure: The Worst Case Scenario Just Got Official (Rating Downgrade) - Seeking Alpha
- 3 days ago - uniQure N.V. (QURE) Q4 2025 Earnings Call Transcript - Seeking Alpha